Rice Acq 3

Establishes the SPAC's terms: trust size, deadline, redemption rights, and sponsor economics. The forward purchase agreement provides a $100M backstop but Mercuria can walk away, creating uncertainty. Sponsor's prior SPACs (Rice I and Rice II) had mixed results: Rice I had 0.2% redemptions and was acquired by BP; Rice II had 61% redemptions and post-merger NET Power stock closed at $2.19/share vs. $16.51 high. CEO Kyle Derham is named in two lawsuits. The trust per share is $10.00, not $10.28 as in user data (likely a later update). No target selected or substantive discussions initiated.

Acceleration requests typically signal internal readiness to close a financing or transaction step, which may precede a business combination announcement, yet the correspondence contains zero substantive claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The letter is authored solely by Chief Financial Officer and Chief Accounting Officer James Wilmot Rogers, who directs further inquiries to Lanchi Huynh of Kirkland & Ellis LLP. For KRSP investors, the document confirms operational continuity under currently filed terms without introducing new redemption triggers, valuation adjustments, or extension votes.

The amendment formally codifies the mechanics governing the trust account and corporate structure that will dictate shareholder outcomes. The registrant confirms a funding target of $300.0 million into the Trust Account (or $345.0 million if the underwriters’ over-allotment option is exercised in full), held at Citibank, N.A. by Odyssey Transfer and Trust Company. The trust mandate restricts interest utilization to franchise or income tax obligations, working capital withdrawals capped at five percent of annual interest earnings, and dissolution costs up to $100,000. Directors and officers expressly waive any right or claim against trust monies outside of their public share ownership. The filing locks in a 24-month operational window (extendable to 27 months upon sponsor election) before mandatory liquidation. Structurally, it records a September 2025 share capitalization that brought the sponsor’s holdings to 11,500,000 Class B units of Opco and 11,500,100 Class B ordinary shares, alongside a commitment to purchase up to 10,650,000 private placement warrants at $1.00 per warrant. Critically, it discloses Exhibit 10.13, a Forward Purchase Agreement dated August 25, 2025, executed among the registrant, Shalennial Acquisition Sponsor 3 LLC, and Mercuria Energy Group Holding, SA, indicating pre-organized capital support ahead of a business combination. Issuance expenses are fixed at $1,250,000, allocated across legal fees ($700,000), SEC/FINRA filings, accounting ($50,000), printing ($40,000), travel ($20,000), NYSE listing fees ($85,000), and miscellaneous costs ($229,887). Deferred underwriting discounts are capped at a maximum of $11,625,000, or $13,368,750 if the over-allotment option is fully exercised.

This regulatory correspondence signals active SEC oversight of the SPAC’s trust distribution mechanism, a core mechanic governing shareholder redemptions and sponsor liquidity. The staff’s demand for reconciliation between the trust agreement, prospectus, and Nasdaq listing rules suggests the current draft funding-release trigger may require rewording before the registration statement clears. Until the amendments are submitted and accepted, the company cannot finalize proxy materials or schedule a vote, potentially pressuring the stated search deadline of October 2, 2027. The trust value per share remains at $10.28, and the filing contains no commentary on target pipeline, transaction fees, sponsor compensation, customer data, or revenue projections. All observations, directives, and referenced clauses originate solely from the Division of Corporation Finance; the document serves as a compliance checkpoint rather than a strategic announcement.

For investors tracking redemption mechanics and trust value, this filing establishes the baseline SPAC structure: trust deposit of $10.00 per unit (initial), a 24-month deadline to consummate a business combination (with a one-time three-month extension option at the sponsor’s election), and a $100 million forward purchase agreement that provides a minimum funding level independent of redemptions (though Mercuria’s commitment may be terminated). The filing also details the 15% redemption cap per beneficial holder (if a shareholder vote is used), the anti-dilution adjustment of founder shares to maintain ~25% ownership, and sponsor conduct provisions including lock-up periods and expense reimbursements.

Management’s stated revisions directly dictate the economic waterfalls available to public shareholders ahead of any redemption deadline or business combination vote. By contractually separating sponsor-owned units from the trust conversion pool and the redemption calculation denominator, the revised registration statement isolates public shareholder claims to the on-deposit balance, which alters the practical dynamics of shareholder approval and cash-out expectations. The explicit mapping of dilution tied to 8,750,000 private warrants and $1,500,000 in convertible working capital loans gives investors management’s projected equity trajectory without requiring external modeling. Updated conflict, financing, and voting disclosures redefine sponsor conduct and acquisition approval pathways. No alterations to the ongoing search status, reported trust balance, or 2027-10-02 expiration are attributed to the Company. All assertions, structural shifts, and compliance rationales are sourced exclusively to Rice Acquisition Corporation 3’s executives and counsel as they reply to SEC Staff directives.

This filing introduces a new SPAC with a sizable trust ($250M) and a $100M forward purchase commitment, providing a strong cash base for a business combination. The sponsor team has prior SPAC success (Rice I and Rice II). The Mercuria partnership adds a global commodity trading firm's deal flow. The 24-month timeline and extension option are standard. Investors should note the dilution from founder shares and warrants, and the forward purchase agreement's termination risk (Mercuria can terminate at any time prior to deal). The trust per share is $10.00, but the dilution table shows significant dilution to public shareholders in maximum redemption scenarios (net tangible book value per share of $(0.80) assuming no redemptions).

SEC pushback on sponsor liquidation waivers and the Opco unit redemption denominator indicates structural ambiguity that could materially alter public shareholder trust yields or voting leverage at a future business combination. Regulatory insistence on transparent dilution modeling for the 8,750,000 private warrants and $1,500,000 working capital facility means the registration statement cannot achieve effectiveness until ownership economics and conflict boundaries are fully priced out for investors. Until these comment items are resolved, the IPO pipeline remains procedurally halted; no trust account movements, extension filings, or redemption windows are triggered by this correspondence.

This filing formalizes the SPAC's IPO structure and timeline, providing investors with key redemption, trust, extension, and sponsor conduct terms. It confirms the trust value ($10.00/share), the 24-month deadline, the forward purchase commitment (which may reduce redemption risk), and the sponsor's low-cost basis creating potential conflicts. The document also updates the SPAC's search status (no target selected) and highlights prior SPAC track record (Rice I and Rice II).

What changed: Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed by Rice Acquisition Corporation 3 (KRSP), a blank-check company still searching for a business combination. The IPO closed on October 2, 2025, generating gross proceeds of $345.0 million. As of December 31, 2025, the trust account held $348,401,782, reflecting interest earnings. The company had $2,585,142 in cash outside the trust account as of that date. The completion window extends to October 2, 2027 (or January 2, 2028, if the sponsor exercises a three-month extension). The company has not yet identified or initiated substantive discussions with any target business. No new forward-purchase agreement, non-redemption, or backstop agreements have been entered into beyond the August 25, 2025 Forward Purchase Agreement described in the IPO registration statement. The company reported a net income of $2,853,706 for the period from inception (June 6, 2025) through December 31, 2025, attributable to $3,401,782 in interest earned on the trust account, offset by $548,076 in operating expenses. Why it matters: This filing is a baseline status report for a newly public SPAC; it confirms the company is actively searching but has not yet found a target. Key metrics are now on the record: trust value per share was approximately $10.10 at year-end ($348.4M / 34.5M public shares). The company has a comfortable cash runway with ~$2.6M outside trust and a long deadline in 2027. The forward purchase agreement ($100M) remains a potential liquidity backstop for a future business combination, though the Mercuria side of the commitment is terminable at will. The filing contains extensive risk-factor disclosure about potential conflicts of interest between the sponsor (a 50/50 joint venture of Rice Investment Group and Mercuria) and public shareholders. The CEO, J. Kyle Derham, discloses he is a named defendant in two ongoing civil lawsuits related to prior SPAC deals (Archaea/Net Power), which is a potential overhang on the management team.

What changed: A Schedule 13G, defined in its own terms as a beneficial ownership report filed pursuant to Section 13(d) of the Securities Exchange Act. The filing records Oaktree Capital Management, L.P.’s cumulative share position but introduces no alterations to KRSP’s October 2, 2027 liquidation deadline, $10.28 trust-per-share balance, redemption mechanics, extension voting, pending business combination progress, or sponsor conduct. It contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel attributable to any party. Why it matters: Because it functions exclusively as a routine compliance exhibit tracking institutional accumulation, it carries zero immediate impact on the SPAC’s capital structure, liquidity triggers, or acquisition timeline. Investors monitoring KRSP’s SEARCHING status should treat this as administrative noise and await formal merger proposals, extension amendments, or trust disbursement schedules for actionable catalysts.

What changed: A Schedule 13G beneficial ownership report filed by Sourcerock Group LLC. The filing registers Sourcerock Group LLC’s current beneficial ownership position for KRSP common stock. It contains no provisions, notices, or disclosures concerning the announced October second, two thousand twenty-seven business combination deadline, the stated ten dollars and twenty-eight cents per-share trust account balance, extension votes, target negotiation status, or sponsor governance actions. Why it matters: Regulatory ownership reports track institutional accumulation and disclose shifts in voting power. Because the provided excerpt lacks accompanying schedules with acquisition dates, percentage thresholds, and price data, it functions solely as a compliance record rather than a catalyst for redemption waves, trust drawdowns, or transaction timing decisions.

What changed: A Schedule 13G, which the document defines as a 'beneficial ownership report.'. Clearbridge Investments, LLC submitted the filing. The document contains no language, schedules, or exhibits that affect KRSP’s redemption mechanics, trust account administration, extension voting procedures, acquisition pipeline, or sponsor governance. Why it matters: As a routine regulatory disclosure of equity holdings, this filing does not advance KRSP’s SEARCHING phase, alter shareholder liquidity windows, or signal impending deal execution. The document attributes zero claims to any party regarding KRSP’s revenue, customer base, market size, strategic roadmap, technology, commercial partnerships, litigation posture, or executive personnel. Consequently, it requires no portfolio action and does not impact investors monitoring the trust account trajectory or business combination timeline.

What changed: A Schedule 13G beneficial ownership report filed on 2026-02-12, formally registering that HITE Hedge Asset Management LLC, HITE Hedge Asset Management LP, and Robert Matthew Niblack are co-reporting persons with respect to KRSP common stock. The provided excerpt contains only the filing type, submission date, SEC form number, and the names of the three reporting entities/individuals. It discloses no share quantities, acquisition dates, purchase prices, acquisition costs, or percentage ownership thresholds. Because all transactional and positional data is omitted from the text, no quantifiable change in beneficial ownership or capital structure can be established from this submission. Why it matters: This Schedule 13G does not reference KRSP’s trust account, redemption calendar, extension votes, target search status, or sponsor conduct. Routine 13G filings indicate that the named parties hold or acquired equity exceeding the statutory reporting threshold, but absent schedule data, statements of purpose, or voting agreements in this excerpt, the filing bears directly on neither shareholder liquidity mechanics nor business combination timelines. If these holders are positioning for a merger vote or intend to influence governance, that strategic context would appear in subsequent amendments or later exhibits; until then, the document functions as a procedural ownership notification with no immediate impact on deal progression or shareholder redemption windows.

What changed: routine compliance exhibit: a Schedule 13G beneficial ownership report filed under federal securities regulations. Filed by REAVES W H & CO INC on 2026-02-06 under accession number 0001999371-26-002686, this filing discloses institutional beneficial ownership without listing share counts, purchase dates, or transaction prices in the provided excerpt. Bearing on SPAC mechanics: the filing references neither the $10.28 trust per share, the 2027-10-02 deadline, any extension proposals, redemption activations, target identification progress, nor sponsor conduct. Bearing on other substance: REAVES W H & CO INC makes no assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel in this submission. Why it matters: Federal securities rules mandate periodic reporting of institutional positions that reach or sustain statutory disclosure thresholds, ensuring transparent capital tracking. For investors monitoring liquidation timelines, conversion mechanics, and sponsor fiduciary behavior, this exhibit signals routine regulatory compliance rather than operational catalysts. It does not adjust the $10.28 trust baseline, alter the 2027-10-02 horizon, or affect the SEARCHING classification, leaving capital allocation parameters and sponsor accountability metrics unchanged.

What changed: Form 8-K Current Report containing a press release announcing the elective separation and standalone trading of Class A ordinary shares and warrants. Trading mechanics updated to allow units to split into shares (KRSP) and warrants (KRSP WS) commencing November 21, 2025. Redemption mechanics remain unchanged; the company retains its October 2, 2027 deadline and ‘SEARCHING’ status. Trust composition is unaffected, and the filing explicitly states only whole warrants will trade with no fractional issuance. The warrant instrument maintains a fixed exercise price of $11.50 per share. No extension votes, sponsor resignations, target acquisitions, or trust drawdowns are triggered. Why it matters: Unit separation grants investors distinct equity and leveraged upside vehicles ahead of a de-SPAC transaction, altering secondary market liquidity dynamics. The press release confirms the operational roadmap: the company will not limit its search to a single industry and instead targets the ‘broadly defined energy value chain, particularly the upstream oil and gas, power generation, energy infrastructure, and critical metals and minerals subsectors.’ Sponsor execution capacity is framed around Rice Investment Group’s deployment of ‘several hundred million dollars since its founding in 2018’ and co-sponsor Mercuria’s platform featuring ‘a team of over 1,200 professionals’ and ‘annual gross revenues exceeding $100 billion over the last few years,’ as detailed in Exhibit 99.1. Investors should factor the $11.50 warrant strike and the unforgiving 2027 deadline into redemption calculations when evaluating whether to hold through a potential merger vote.

What changed: A Joint Filing Agreement attached to Exhibit 99.1 for a Schedule 13G beneficial ownership report, executed by Rice Acquisition Sponsor 3 LLC, Daniel J. Rice, IV, and J. Kyle Derham to consolidate their reporting obligations under Rule 13d-1(k)(1). The filing creates a joint reporting mechanism for Class A ordinary shares, par value $0.0001 per share, of Rice Acquisition Corporation 3. It does not disclose any amendments to the redemption calendar, the $10.28 trust value per share, the October 2, 2027 deadline, extension provisions, or target combination status. Sponsor conduct remains aligned with standard SEC compliance routines; execution was carried out by attorney-in-fact James Wilmot Rogers under Powers of Attorney dated September 30, 2025. Why it matters: This is a procedural compliance exhibit that streamlines filing duties among affiliated insiders without modifying shareholder redemptions, cash balances, or acquisition timelines. The document contains no business claims, financial projections, customer or revenue data, market sizing, strategic initiatives, technology disclosures, partnership arrangements, litigation references, or personnel updates; all statements are confined to the administrative agreement to file jointly and the recitation of stock class terminology.

What changed: Form 10-Q quarterly report for Rice Acquisition Corporation 3 (KRSP) for the period ended September 30, 2025, its first periodic filing since inception (June 6, 2025). The report covers the pre-IPO period and describes the IPO completed on October 2, 2025, as a subsequent event. The SPAC had no operations in the quarter; all activity was organizational and preparatory for the IPO. The IPO closed after the balance sheet date, raising $345,000,000 (34,500,000 units at $10.00) with full over-allotment exercise. Simultaneously, $10,650,000 was raised via private placement warrants to the sponsor. A forward purchase agreement for $100,000,000 (10,000,000 shares at $10.00) was entered into with Shalennial Acquisition Sponsor 3 LLC and Mercuria Energy Group Holding, SA, though Mercuria may terminate its commitment at any time. The sponsor loan of $300,000 was fully repaid on October 17, 2025. The company has not selected any business combination target and has not engaged in substantive discussions. The combination period is 24 months (27 months if sponsor exercises its three-month extension). Why it matters: This filing establishes the SPAC's baseline financial condition, trust account size ($345,000,000, $10.00 per public share), sponsor and director ownership structure (11,500,100 Class B shares), warrant terms, and the forward purchase agreement that provides additional minimum funding. Investors can assess the trust value per share, redemption mechanics, and the sponsor's commitments. The forward purchase agreement's $100 million backstop is conditional and Mercuria can withdraw, which introduces uncertainty. The filing also details the administrative services agreement ($20,000/month to sponsor) and working capital position.

What changed: Schedule 13G beneficial ownership report [0001172661-25-004200]. The filing asserts that Encompass Capital Advisors LLC, Todd J. Kantor, and Encompass Capital Partners LLC hold reportable beneficial ownership in KRSP. The provided excerpt lists only the filers’ names and the form title; it contains no share counts, percentages, acquisition dates, or purchase prices, so no change in holding quantity or cost basis is disclosed. Why it matters: As a routine compliance exhibit triggered by crossing the statutory reporting threshold, the filing does not bear on redemption deadlines, trust value, extension timelines, deal progress, or sponsor conduct. The reporting persons make no statements regarding pursuit of a business combination, nor do they advance any claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. No other assertions are attributed to management, sponsors, or third parties in the text; the filing exclusively registers the reporting persons’ beneficial ownership positions. Without share quantities or a purpose clause, the filing offers no actionable signal for investor tracking mechanics.